ACRS
#2641
Aclaris Therapeutics, Inc. - Common Stock
5.5 0 USD
-0.01%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-1.43%
Monthly Change
+24.15%
6 month change
+100.00%
Year Change
+250.32%
Previous Close
5.5 8
Open
5.5 0
Low
5.5 0
High
5.5 0
Volume
100
Financials
- Market Capitalization 768.15 M
- Employee 73
- Founded 2012
- CEO N/A
- Website www.aclaristx.com
- Headquarter Delaware, United States
- FIGI BBG003LF0QR9
- Industry Diagnostics & Research
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-5.68
Price to sales ratio
47.14
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2191 |  CDNA CareDx, Inc. - Common Stock | 28.76 USD | +0.88% | -2.04% | +24.93% | +92.89% | 1.49 B USD | ||
| 2522 |  OPK Opko Health, Inc. - Common Stock | 1.23 USD | -8.89% | -17.45% | -13.99% | -8.89% | 928.76 M USD | ||
| 2697 |  CSTL Castle Biosciences, Inc. - Common stock | 22.98 USD | -3.12% | -5.67% | +10.85% | -6.64% | 696.98 M USD | ||
| 2823 |  FLGT Fulgent Genetics, Inc. - Common Stock | 20.42 USD | -0.63% | -4.98% | +8.39% | -13.58% | 579.94 M USD |
Frequently asked questions about Aclaris Therapeutics, Inc. - Common Stock
What is the Aclaris Therapeutics, Inc. - Common Stock stock price today?
The current price of Aclaris Therapeutics, Inc. - Common Stock (ACRS) is 5.5. Over the past 24 hours, the stock has changed by -1.43%. Follow the ACRS chart for real-time price dynamics.
What is the stock ticker of Aclaris Therapeutics, Inc. - Common Stock?
Aclaris Therapeutics, Inc. - Common Stock trades under the ticker ACRS. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Aclaris Therapeutics, Inc. - Common Stock stock going up?
ACRS has changed by +0.73% over the last week, +24.15% over the last month, and +250.32% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Aclaris Therapeutics, Inc. - Common Stock net income for the last quarter?
Aclaris Therapeutics, Inc. - Common Stock reported net income of -19.82 M for the last quarter. The previous quarter showed -19.8 M, which means net income changed by -0.15%.
How many employees does Aclaris Therapeutics, Inc. - Common Stock have?
As of the latest available data, Aclaris Therapeutics, Inc. - Common Stock has 73 employees. Workforce size can provide additional context about the company's scale and operations.
What is Aclaris Therapeutics, Inc. - Common Stock EBITDA?
Aclaris Therapeutics, Inc. - Common Stock EBITDA is -22.09 M, and its EBITDA margin is -1 106.71%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Aclaris Therapeutics, Inc. - Common Stock stock?
You can buy Aclaris Therapeutics, Inc. - Common Stock (ACRS) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Aclaris Therapeutics, Inc. - Common Stock stock?
Investing in Aclaris Therapeutics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the ACRS chart and related analysis on metatrader.com as part of your research.